What A Collab! Optimi Health & Patient Advocate Thomas Hartle's New Medical Psilocybin Venture

Optimi Health Corp. (OTCQX: OPTHF), the Canadian licensed psychedelic and functional mushrooms producer has signed a partnership agreement with psilocybin patient advocate Thomas Hartle to produce a novel homegrown, natural therapeutic psilocybin product for approved patients.

Who Is Thomas Hartle?

While Optimi’s work might be familiar to many, Thomas Hartle is a husband, father, IT professional and the first Canadian to legally receive psilocybin-assisted psychotherapy for his stage 4 colon cancer diagnosis. The treatment began in August 2020 and has enabled him to experience a substantial improvement in his overall well-being, which has in turn compelled him to become an active supporter of it.

Full story available on Benzinga.com

What A Collab! Optimi Health & Patient Advocate Thomas Hartle's New Medical Psilocybin Venture on Benzinga